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Diaminobutyric polypropylenimine (DAB) dendrimers have been shown to be highly 
efficient non-viral gene delivery systems for cancer therapy. However, their cytotoxicity currently 
limits their applications. To overcome this issue, PEGylation of DAB dendrimer, using various 
PEG molecular weights and dendrimer generations, has been attempted to decrease the 
cytotoxicity and enhance the DNA condensation, size and zeta potential, cellular uptake and 
transfection efficacy of these dendriplexes. Among all the PEGylated dendrimers synthesized, 
generation 3- and generation 4-DAB conjugated to low molecular weight PEG (2 kDa) at a 
dendrimer: DNA ratio of 20:1 and 10:1 resulted in an increase in gene expression on almost all 
tested cancer cells lines (by up to 3.2-fold compared to unmodified dendrimer in A431 cells). The 
KLJKHVW OHYHORIȕ-galactosidase gene expression (10.07x10-3 ± 0.09x10-3 U/mL) was obtained 
following treatment of B16F10-Luc cells with G4-dendrimer PEGylated with PEG2K at a 
dendrimer: DNA ratio of 20:1. These delivery systems significantly decreased cytotoxicity on 
B16F10-Luc cells, by more than 3.4-fold compared to unmodified dendrimer. PEGylated 
generations 3- and 4-DAB dendrimers are therefore promising gene delivery systems for cancer 
therapy, combining low cytotoxicity and high transfection efficacy. 
 
Keywords: PEGylation; polypropylenimine dendrimer; gene delivery; non-viral 
vectors; cancer gene therapy 
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Introduction 
Gene therapy has become one of the most intensively studied strategies for the treatment 
of various diseases, ranging from monogenic diseases such as cystic fibrosis to complex 
disorders such as cancer1. Despite numerous advances, the use of therapeutic genes in 
cancer treatment is still limited by the lack of safe and efficacious gene delivery vectors2. 
To overcome this problem, various non-viral vectors, such as cationic liposomes and 
cationic polymers, are currently under development, due to advantages such as their 
simplicity to use, ease of production and quality control, high DNA carrying capacity, 
low immunogenicity and their ability to achieve prolonged exogenous gene expression3. 
Among these non-viral delivery systems, dendrimers appear to be particularly promising, 
owing to their well-defined size and structure, low polydispersity and high transfection 
efficiency4-6. In particular, diaminobutyric polypropylenimine (DAB) dendrimer has been 
demonstrated to be an efficient non-viral vector for targeted gene delivery to cancer7-11 
and to the brain12-13. However, DAB dendrimer show concentration- and generation-
dependent toxicity, caused by the presence of surface primary amines14, which impedes 
their clinical development. In addition, dendrimers and other cationic polymers are 
rapidly eliminated from the systemic circulation by the mononuclear phagocyte system, 
thus reducing their efficacy.  
PEGylation, the conjugation of polyethylene glycol (PEG) to cationic polymers, 
is one of the most widely used strategies to shield positive charges and therefore reducing 
toxicity, macrophage uptake, aggregation and opsonisation, ultimately improving 
circulation times15. However, positively charged surface primary amines of the dendrimer 
are essential to electrostatically bind to the negatively charged phosphate groups of 
DNA4. PEGylation of these surface primary amines could modify the physicochemical 
properties of the dendrimer, thus impacting on its interactions with DNA and its 
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transfection efficacy. Previous studies using generation 5-polyamidoamine (PAMAM) 
dendrimer demonstrated that the modification of this dendrimer with PEG 3.4 kDa 
resulted in a 20-fold increase in transfection efficacy compared to naked PAMAM 
dendrimer in Chinese hamster ovarian (CHO) cells16. However, modification of the same 
dendrimer with PEG having a different molecular weight (550 Da) led to a decrease in 
transfection efficiency in the same cell line17. Both studies reported a decrease in the 
cytotoxicity of the dendrimer, but an opposite outcome regarding gene expression. 
PEGylation of dendrimers and its impact on transfection efficacy appear to be governed 
by various factors such as dendrimer generation, PEG molecular weight, degree of 
PEGylation and tested cell lines. 
The aim of this study is therefore to investigate the influence of the conjugation 
of PEG with various molecular weights to DAB dendrimers with various generations, on 
the cytotoxicity, physicochemical properties, DNA condensation, cellular uptake and 
transfection efficacy of the dendriplexes. 
 
 
 
Results 
Synthesis of PEGylated PPI dendrimers  
1H NMR confirmed the synthesis of PEGylated DAB dendrimers. For representation we 
have shown the synthesis of G3-DAB dendrimer conjugated to M-PEG2K 
(Supplementary Fig. 1). The characteristic peaks of G3-DAB were 1H-NMR (D22į
DAB (N-CH2-CH2-CH2-CH2-1 į'$%1-CH2-CH2-CH2-1 į'$%
(N-CH2-CH2-CH2-NH2 į'$%1-CH2-CH2-CH2-1+ į'$%1-CH2-
CH2-CH2-1 į'$%1-CH2-CH2-CH2-NH2) = 2.91. The characteristic peaks of 
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of M-PEG2K are 1H-NMR (D22į0-PEG2K (CH3-O- į0-PEG2K (CH2-
CH2-O)  į0-PEG2K (CH2-C=O) = 4.1. The final product G3-PEG2K presented 
the characteristic peaks from both G3-DAB and M-PEG2K. The protons of the 
succinimidyl group of M-PEG2K disappeared in the final product due to the formation 
of amide bond with the primary amine groups of G3 DAB dendrimer. The characteristic 
peak of the methylene protons next to the amide bond was observed at 3.89 ppm. 
The number of PEG chains attached to each dendrimer was calculated by ratios 
of integration between peaks at ~1.57 and 3.33 (Supplementary Fig. 2-4). The number of 
M-PEG2K chains attached to G3-, G4- and G5-DAB dendrimer was 2.7, 2.7 and 2 
respectively, whereas the number of M-PEG5K chains attached to the G3, G4 and G5 
DAB dendrimers was 5.3, 2.4, 3.7 respectively, and the number of M-PEG10K chains 
attached to G3, G4 and G5 DAB dendrimers was 6.2, 2.3 and 6.2 respectively. 
 
Impact of PEGylation on cytotoxicity 
Dendrimers with free peripheral primary amine groups are widely known to exhibit 
concentration- and generation-dependent cytotoxicity. The conjugation of PEG with 
various molecular weights led to a decrease in the cytotoxicity of all DAB dendrimers on 
B16F10-Luc cells (Table 1, Fig. 1). The conjugation of PEG with various molecular 
weights to G3-DAB dendrimer resulted in a minimum of 5.3-fold decrease in cytotoxicity 
(IC50 for unmodified G3-GHQGULPHUȝJP/,&50 for G3-DAB conjugated 
to M-PEG2K, M-PEG5K, M-3(*. KLJKHU WKDQ  ȝJP/ 7KHVH 3(*\ODWHG
dendrimers were the least cytotoxic among all those tested, with more than 50% cells 
EHLQJVWLOOYLDEOHDWWKHKLJKHVWWHVWHGFRQFHQWUDWLRQȝJP/Fig. 1A).  
The conjugation of PEG to G4-DAB, which was more cytotoxic than G3-DAB, 
led to a decrease in cytotoxicity by more than 2.5-fold (IC50 for unmodified G4-
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GHQGULPHUȝJP/,&50 for G4-DAB conjugated to M-PEG2K, M-PEG5K, 
M-3(*.UHVSHFWLYHO\ȝJP/ȝJP/DQGKLJKHUWKDQ
ȝJP/ 3(*\ODWLRQ GHFUHDVHG F\WRWR[LFLW\ EXW ZLWK OLPLWHG HIILFDF\ DV RQO\ D
maximum of 20% RIFHOOVZHUHVWLOOYLDEOHDWD WUHDWPHQWFRQFHQWUDWLRQRIȝJP/
(Fig. 1B).  
The conjugation of PEG to G5-DAB, which was the most cytotoxic of the 3 
unconjugated dendrimers, led to a limited decrease of cytotoxicity, with M-PEG10K 
being the most efficacious (IC50 for unmodified G5-GHQGULPHUȝJP/,&50 
for G5-DAB conjugated to M-3(*.ȝJP//HVVWKDQRIWKHFHOOV
ZHUH VWLOO YLDEOH DW D WUHDWPHQW FRQFHQWUDWLRQ RI  ȝJP/ LQGHSHQGHQWO\ RI WKH
molecular weight of PEG used for conjugation (Fig. 1C).  
 
Impact of PEGylation on DNA condensation efficiency 
All unmodified DAB dendrimers were able to efficiently condense at least 70% of 
negatively charged plasmid DNA to form dendriplexes, at all dendrimer: DNA weight 
ratios (Fig. 2). DNA complexation occurred instantly and was stable for 24 hours. 
The conjugation of M-PEG2K, M-PEG5K, M-PEG10K to G3-DAB dendrimer 
led to a decrease in the DNA condensation efficiency. DNA condensation efficiency of 
G3- PEGylated dendrimers decreased when the molecular weight of conjugated PEG 
increased: G3-PEG2K was able to condense more than 70 % of the DNA at the weight 
ratios of 5:1 and higher. However, a similar DNA condensation percentage could only be 
reached with G3-PEG5K and G3-PEG10K at the dendrimer: DNA weight ratios of 10:1 
and 20:1.  
PEGylation of G4-DAB dendrimer followed a similar pattern, but with a generally 
enhanced DNA condensation compared to what observed with PEGylated G3-DAB 
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dendrimers. G4-PEG2K and G4-PEG5K were able to condense more than 70 % of the 
DNA at the weight ratios of 2:1 and higher (compared to the 5:1 and 10:1 ratios needed 
in the case of G3-dendrimer). G4-PEG10K was less effective, with a similar DNA 
condensation percentage only reached at the dendrimer: DNA weight ratios of 5:1 and 
above. 
PEGylation of G5-DAB dendrimer resulted in an even further enhanced DNA 
condensation compared to that observed with PEGylated G4-DAB dendrimers. G5-
PEG2K and G5-PEG5K were as effective as G4-PEG2K and G4-PEG5K, but G5-
PEG10K was able to condense more than 70 % of the DNA at the dendrimer: DNA weight 
ratios of 2:1 and higher. 
 
Impact of PEGylation on size and zeta potential of dendriplexes and dendrimers 
The conjugation of M-PEG2K, M-PEG5K and M-PEG10K to G3- and G4-DAB 
dendrimers led to a decrease in the size of the dendriplex at the high dendrimer: DNA 
weight ratios of 20:1 and 10:1 (Fig. 3). The same conjugation on G5-DAB dendrimer did 
not result in any significantly different size change of the dendriplex. At low dendrimer: 
DNA weight ratios (from 2:1 and below), all PEGylated dendriplexes showed an 
increased size due to the weaker interactions between PEGylated DAB dendrimers and 
anionic plasmid DNA. 
The conjugation of M-PEG2K, M-PEG5K and M-PEG10K to DAB dendrimers resulted 
in a decrease in the zeta potential of all dendriplexes at all the tested dendrimer: DNA 
weight ratios (Fig. 3). The decrease in the zeta potential was directly proportional to an 
increase in the molecular weight of PEG: zeta potential was the lowest following 
conjugation of PEG10K for all 3 G3-, G4- and G5-DAB dendrimers. At low dendrimer: 
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DNA weight ratios (2:1 and below), negative zeta potentials were recorded, due to 
insufficient binding between the PEGylated dendrimers and pDNA. 
The size of all PEGylated dendrimers was slightly higher than that of non-PEGylated 
dendrimers (Supplementary Table 1). For G3-DAB dendrimer, it increased with the size 
of the conjugated PEG chains (1.73 ± 0.02 nm for non-PEGylated G3-DAB, from 3.14 ± 
0.16 nm for G3-PEG2K to 6.1 ± 0.13 nm for G3-PEG10K). For G4-DAB dendrimer, the 
size of the dendrimer mainly increased following conjugation of M-PEG5K and M-
PEG10K (2.01 ± 0.04 nm for non-PEGylated G4-DAB, 5.25 ± 0.72 nm and 6.54 ± 0.27 
nm for G4-PEG5K and G4-PEG10K respectively). For G5-DAB dendrimer, it was the 
highest following grafting with M-PEG10K (2.53 ± 0.07 nm for G5-DAB, 6.43 ± 0.24 
nm for G5-PEG10K).   
The zeta potential of the PEGylated dendrimers was significantly lower than that of non-
PEGylated dendrimers (with the exception of G3-dendrimer and G3-DAB2K). Grafting 
M-PEG10K to G3-, G4- and G5-dendrimers led to the lowest zeta potential among 
PEGylated dendrimers (8.41 ± 0.42 nm, 8.74 ± 0.14 nm and 10.3 ± 0.22 nm respectively 
for G3-10K, G4-10K and G5-10K, 13.05 ± 0.59 nm, 25.26 ± 0.78 nm and 41.5 ± 1.52 nm 
respectively for G3-, G4- and G5-DAB) (Supplementary Table 2).  
 
Impact of PEGylation on transfection 
The PEGylation of DAB dendrimers led to an increase in transfection for some specific 
generation-dependent dendrimers, PEG molecular weight, dendrimer: DNA weight ratio, 
and depending on the cell line (Fig. 4). This transfection increase did not follow any trend 
applicable to all dendrimers with one given PEG.  
PEGylated G3-dendrimers led to a transfection increase (by 1.1-fold compared to 
unmodified dendrimer) only following conjugation of PEG2K, at a dendrimer: DNA 
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weight ratio of 20:1 on B16F10-Luc cells. The highest gene expression obtained in PC3-
Luc cells (increase of 2.7-fold compared to unmodified dendrimer) was also obtained 
with the same conditions. However, on A431 cells, gene expression was increased for 
almost all tested PEG molecular weights and dendrimer: DNA weight ratios (up to 2.2-
fold), except when using M-PEG5K at a dendrimer: DNA ratio of 5:1. On T98G cells, 
PEGylation did not result in any transfection increase compared to the native G3-
dendrimer.  
G4-dendrimer PEGylated with PEG2K led to a transfection increase for all the 
tested cell lines at a dendrimer: DNA ratio of 20:1 and/or 10:1 (up to 1.1-fold in B16F10-
Luc cells, up to 3.2-fold in A431 cells, up to 1.3-fold in T98G cells, up to 1.4-fold in 
DU145 cells, up to 1.3-fold in PC3-Luc cells compared to unmodified dendrimer). On 
A431 cells, conjugation of PEG5K and 10K could lead to a more modest transfection 
increase (by 2.3-fold and 1.9-fold respectively), when used at a dendrimer: DNA ratio of 
20:1.  
G5-dendrimer conjugated to PEG2K resulted in a transfection increase as well on 
B16F10-Luc (up to 1.1-fold), A431 (up to 1.5-fold), DU145 (up to 1.4-fold) and PC3-
Luc cells (up to 2.7-fold), but not on T98G cells. This increase was observed at various 
dendrimer: DNA weight ratios, depending on the cell line. On T98G, DU145 and PC3-
Luc cells, the conjugation of PEG with a molecular weight of 5 or 10K resulted as well 
in an increase in transfection, for some specific dendrimer: DNA ratios (up to 1.1-fold in 
T98G cells, up to 1.4-fold in DU145 cells, up to 1.7-fold in PC3-Luc cells). 
The highest transfection increase was therefore obtained following treatment of 
A431 cells with G4-dendrimer PEGylated with PEG2K at a dendrimer: DNA ratio of 
10:1 (up to 3.2-IROG FRPSDUHG WR XQPRGLILHG GHQGULPHU 7KH KLJKHVW OHYHO RI ȕ-
galactosidase gene expression (10.07x10-3 ± 0.09x10-3 U/mL) resulted from the treatment 
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of B16F10-Luc cells with G4-dendrimer PEGylated with PEG2K at a dendrimer: DNA 
ratio of 20:1.  
  
Impact of PEGylation on cellular uptake 
To determine if there was a correlation between levels of transfection and cellular uptake 
of the dendriplexes, we treated B16F10-Luc cells with various dendriplexes that showed 
high levels and low levels of transfection and determined the cellular uptake qualitatively 
using confocal microscopy and quantitatively using flow cytometry. G3-PEG2K (20:1), 
G3-PEG5K (20:1) and G3-PEG10K (20:1) dendriplexes, that led to high levels of 
transfection, resulted in higher cellular uptake than that of G3-PEG2K (2:1), G3-PEG5K 
(5:1) and G3-PEG10K (5:1) dendriplexes respectively (Fig. 5). G4-PEG2K (10:1) 
dendriplex, which led to high transfection, unexpectedly showed lower cellular uptake 
compared to G4-PEG2K (2:1) dendriplex which led to lower transfection (Fig. 6). G5-
PEG2K (5:1), G5-PEG5K (5:1) and G5-PEG10K (10:1) dendriplexes, that led to higher 
transfection levels, also showed moderately higher cellular uptake compared to G5-
PEG2K (2:1), G5-PEG5K (2:1) and G5-PEG10K (2:1) dendriplexes that resulted in low 
transfection efficiency (Fig. 7). 
 
 
Discussion 
To our knowledge, this is the first report methodically studying the effect of the 
conjugation of PEG with various molecular weights to generations 3-, 4- and 5-
diaminobutyric polypropylenimine dendrimers, on their cytotoxicity, DNA condensation, 
size and zeta potential, transfection and cellular uptake efficacy. We have successfully 
conjugated M-PEG2K, M-PEG5K and M-PEG10K to the primary amine groups on the 
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surface of G3-, G4- and G5-DAB dendrimers through an amide bond formation. These 
primary amines have been described to exert dose-dependent and generation-dependent 
toxicity through formation of nanoholes in the cellular membrane18. 
Toxicity is one of the major limitations for using dendrimers as gene delivery 
systems, in particular for high generation dendrimers that theoretically lead to higher 
transfection. The conjugation of PEG with various molecular weights to DAB dendrimers 
of various generations led to a decrease in the cytotoxicity of the dendrimers by shielding 
their surface positive charges. Specifically, the conjugation of M-PEG2K, M-PEG5K and 
M-PEG10K to G3-DAB dendrimer led to the most significant decrease in cytotoxicity 
among all the tested dendrimers. For G4-DAB and G5-DAB dendrimers, the highest 
decrease in cytotoxicity was observed following conjugation of M-PEG10K. Expectedly, 
the size of all PEGylated dendrimers was slightly higher than that of unmodified 
dendrimers, but did not correlate with a specific trend regarding the decrease in 
cytotoxicity observed in the study. These very small sizes need to be considered with 
caution, as they are in limit of detection of the Zetasizer. The zeta potential of the 
PEGylated dendrimers was statistically lower than their non-PEGylated counterparts 
(with the exception of G3-dendrimer and G3-DAB2K) due to the charge-shielding effect 
of PEG, and therefore did have a positive impact on cytotoxicity. Cell viability has 
previously been reported to be negatively influenced by possible intermolecular 
agglomeration of the PEGylated dendrimers through twinning of long PEG chains, that 
occurs at high concentrations19-20. However, this eventual agglomeration did not impact 
on cytotoxicity in this study: the conjugation of high molecular weight M-PEG10K to the 
G5-DAB dendrimer decreased its cytotoxicity compared to the other PEGylated G5-
dendrimers. This result is in accordance with similar reduction of toxicity reported when 
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conjugating G5-PAMAM dendrimer to PEG 3.4 kDa 16, hyperbranched PAMAM to PEG 
2kDa 21 and G5- and G6- PAMAM to PEG 5K 22.  
The charge-shielding effect of PEG had a substantial effect on the DNA 
condensation efficiency of the different generations of DAB dendrimers. Increase in the 
molecular weight of PEG conjugated to DAB dendrimers led to a decrease in the DNA 
condensation efficiency at lower dendrimer: DNA weight ratios. At higher ratios, stable 
dendriplex formation with DNA condensation with more than 70% DNA condensation 
efficiency was recorded. Hashemi et al.23 reported similar results with a slight decrease 
in the DNA condensation ability of the G5-DAB dendrimer modified with PEG (MW: 
3.4 kDa).  Furthermore, G5-PAMAM dendrimer modified with PEG (MW: 3.4 and 5 
kDa) showed an increased ability to compact DNA compared to unmodified dendrimers16, 
24
. These results can be explained by the fact that the conjugation of PEG to cationic 
dendrimers led to steric stabilization of the electrostatic interactions between the 
dendrimer and the plasmid DNA. 
PEGylated G3- and G4-DAB dendriplexes showed a lower size compared to the 
non-PEGylated dendriplexes only at high dendrimer: DNA weight ratios (20:1 and 10:1). 
The conjugation of PEG chains imparted flexibility to the dendrimers, leading to the 
formation of more compact dendriplexes at high dendrimer: DNA weight ratios25. A 
similar decrease in the size of the dendriplexes was reported when G5- and G6-PAMAM 
dendrimers were conjugated to PEG (MW: 5 kDa)24. When these dendrimers were 
modified with PEG (MW: 3.4 kDa), the size of the resulting PEGylated dendriplexes 
were smaller than that of the unmodified PAMAM dendrimers23.  
The cationic surface charge is one of the important determinants of the dendrimer-
mediated cytotoxicity. PEGylation of dendrimers led to charge shielding effects, thus 
increasing the biocompatibility. The conjugation of PEG led to a decrease in the zeta 
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potential of the dendriplexes compared to the unmodified dendriplexes. Similar results 
were reported following conjugation of PEG to various polymers24. A decrease in zeta 
potential should reduce the interactions with serum proteins and uptake by the 
reticuloendothelial system in vivo, leading to longer circulation time of the 
dendriplexes26. It should also increase the hemocompatibility of the dendriplexes26.   
Dendriplex-mediated transfection was hindered by various rate-limiting steps 
such as cellular uptake, endosomal escape and nuclear entry. These rate-limiting steps are 
controlled by a complex interplay between the DNA condensation efficiency, size, zeta 
potential and surface characteristics of the dendriplexes, which ultimately depend on the 
generation of dendrimer and the PEG molecular weight. In this study, we reported 
significantly higher transfection levels by PEGylated dendrimers at higher dendrimer: 
DNA weight ratios (20:1 and 10:1) compared to unmodified dendrimers. The conjugation 
of PEG to the DAB dendrimers imparts higher flexibility and steric stabilization of the 
complexes. In addition, PEGylation creates charge separation between the positively 
charged dendrimers and negatively charged DNA, which aids the cytoplasmic release of 
plasmid DNA from the dendriplex, thus facilitating nuclear entry. PEGylated 
dendriplexes that led to higher transfection levels than non-PEGylated dendriplexes also 
showed higher cellular uptake. However, some G4- and G5-PEGylated dendriplexes 
showed low transfection levels, despite having higher cellular uptake. This demonstrates 
that the correlation between cellular uptake and transfection is complicated, cell line-
dependent and governed mainly by internal cellular machinery, more than the 
extracellular factors. Similar increases in the levels of transfection after PEGylation of 
dendrimers have been reported before16,23. This is the first reported data showing the 
impact of PEG molecular weight on the transfection efficiencies of the different 
generations of DAB dendrimers on various cell lines. 
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Methods 
Cell lines and reagents 
Generations 3-, 4- and 5- diaminobutyric polypropylenimine (DAB) dendrimers were 
purchased from Symo-Chem (Eindhoven, The Netherlands). Methoxy PEG succinimidyl 
carboxymethyl esters of various molecular weights (2 kDa, 5 kDa and 10 kDa) came from 
-HQNHP7HFKQRORJ\3ODQR7;86$7KHH[SUHVVLRQSODVPLGHQFRGLQJȕ-galactosidase 
S&09VSRUW ȕ-galactosidase) was obtained from Invitrogen (Paisley, UK). It was 
purified using an Endotoxin-free Giga Plasmid Kit (Qiagen, Hilden, Germany). Quanti-
iT PicoGreen dsDNA reagent and tissue culture media were purchased from Life 
7HFKQRORJLHV3DLVOH\8.9HFWDVKLHOGPRXQWLQJPHGLXPFRQWDLQLQJ¶-diamino-2-
phenylindole (DAPI) was obtained from Vector Laboratories (Peterborough, UK). Label 
IT Fluorescein Nucleic Acid Labelling Kit was from Cambridge Biosciences (Cambridge, 
UK). Passive lysis buffer was obtained from Promega (Southampton, UK). All other 
materials were purchased from Sigma Aldrich (Poole, UK). Bioware PC-3M-luc-C6 
human prostate adenocarcinoma and Bioware B16-F10-luc-G5 mouse melanoma were 
obtained from Caliper Life Sciences (Hopkinton, MA, USA), while A431 human 
epidermoid carcinoma, T98G human glioblastoma and DU145 human prostate carcinoma 
were purchased from the European Collection of Cell Cultures (Salisbury, UK). 
 
Synthesis of PEGylated diaminobutyric polypropylenimine (DAB) dendrimers 
PEGylated dendrimers were synthesized following the one-step reaction of generation 3, 
4- or 5- DAB dendrimers with the amine-reactive methoxy PEG succinimidyl 
carboxymethyl esters (molecular weights: 2 kDa, 5 kDa and 10 kDa) (M-PEG). Briefly, 
DAB dendrimers (10 mg) were dissolved in 5 mL of 50 mM sodium phosphate and 0.15 
M sodium chloride buffer (pH 7.5). The amine-reactive M-PEG with various molecular 
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weights were then added to each DAB dendrimer (10 mg) in 4 mole-excess (47.2 mg, 
22.4 mg and 10.4 mg M-PEG 2 kDa reacting with respectively G3-, G4- and G5-
dendrimers; 118 mg, 56 mg and 26 mg M-PEG 5 kDa reacting with respectively G3-, G4- 
and G5-dendrimers; 236 mg, 112 mg and 52 mg M-PEG 10 kDa reacting with 
respectively G3-, G4- and G5-dendrimers) for 8 hours at 25 oC with continuous stirring, 
yielding a total of 9 different PEGylated dendrimers. The final compounds were purified 
by dialysis against distilled water (1.8 L, changed twice) for 24 h at 25°C, using dialysis 
tubings with molecular weight cut-offs of 3.5 kDa, 7 kDa and 12-14 kDa to remove excess 
M-PEG, before being freeze-dried. The PEGylation of the dendrimers was confirmed by 
1H NMR spectroscopy, using a Jeol Oxford NMR AS 600 spectrometer (Peabody, MA, 
USA). The final products were designated as G3-PEG2K, G3-PEG5K, G3-PEG10K, G4-
PEG2K, G4-PEG5K, G4-PEG10K, G5-PEG2K, G5-PEG5K and G5-PEG10K, 
depending on the generation of dendrimer and molecular weight of PEG. 
 
Cytotoxicity  
The cytotoxicity of the PEGylated DAB dendrimers was assessed using a MTT assay. 
B16F10-Luc cells were seeded in quintuplicate at a density of 5 000 cells/well in 96-well 
plates for 24 hours before treatment. They were then incubated for 72 hours with various 
PEGylated dendrimers in concentrations ranging from 20 to 180 µg/mL, using untreated 
cells as negative controls and cells treated with 1% Triton X as positive controls. 
Absorbance was measured at 570 nm using a plate reader and the growth inhibitory 
concentration for 50% of the cells (IC50) was measured. Dose-response curves were fitted 
to percentage absorbance values to obtain IC50 values (n=15). 
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DNA condensation efficiency  
The ability of PEGylated DAB dendrimers to successfully complex plasmid DNA was 
assessed using a PicoGreen assay, following the protocol provided by the supplier. 
PicoGreen reagent was diluted 200-fold in Tris-EDTA (TE) buffer (10 mM Tris, 1mM 
EDTA, pH 7.5) just before the experiment. One mL of PEGylated DAB: DNA dendriplex 
at various dendrimer: DNA weight ratios (20:1, 10:1, 5:1, 2:1, 1:1 and 0.5:1) was added 
to one mL of the diluted PicoGreen reagent. The DNA concentration in the cuvette (10 
µg/mL) remained constant throughout the whole experiment. The fluorescence intensity 
of PicoGreen in presence of the formed dendriplexes was measured at various times using 
a Varian Cary Eclipse fluorescence spectrophotometer (Palo Alto, CA86$Ȝexc: 480 
QPȜem: 520 nm). Results were presented as percentages of DNA condensation.  
 
Size and zeta potential measurement of dendriplexes and dendrimers 
The size and zeta potential of the PEGylated DAB dendriplexes were measured for 
various dendrimer: DNA weight ratios (20:1, 10:1, 5:1, 2:1, 1:1, and 0.5:1) respectively 
by photon correlation spectroscopy and laser Doppler electrophoresis, using a Malvern 
Zetasizer Nano-ZS at 37°C (Malvern Instruments, Malvern, UK). The DNA 
concentration was 50 µg per 1 mL sample.  
PEGylated and non-PEGylated dendrimers also had their size and zeta potential 
measured. For size measurement, dendrimer concentration was 5 mg per mL glucose 5% 
solution for non-PEGylated G5-dendrimers, and 10 mg per mL glucose 5% solution for 
all other PEGylated and non-PEGylated dendrimers. Size data were reported as size by 
volume. For zeta potential determination, the dendrimer concentration was 2 mg per 1 
mL glucose 5 % solution for all PEGylated and non-PEGylated dendrimers. 
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Transfection 
The transfection efficiency of the DNA complexed by PEGylated DAB dendrimers on 
YDULRXVFDQFHUFHOOOLQHVZDVDVVHVVHGXVLQJDSODVPLG'1$HQFRGLQJȕ-galactosidase. 
To this end, B16F10-Luc, A431, T98G, PC3 and DU145 cells were seeded at a 
concentration of 2 000 cells/well in 96-well plates and incubated for 72 h at 37 °C in a 
5% CO2 atmosphere. They were then treated with PEGylated dendriplexes in 
quintuplicate at various dendrimer: DNA weight ratios (20:1, 10:1, 5:1, 2:1, 1:1 and 
0.5:1). Naked DNA was used as a negative control. Generations 3-, 4- and 5- DAB 
complexed to DNA served as positive controls, with a dendrimer: DNA weight ratio of 
2:1 that was shown to be leading to the highest gene expression (Supplementary Fig. 5).  
DNA concentration (1 µg/ well) was kept constant throughout the experiment. The 
volume of the treatment per well was 0.2 mL. After treatment, the cells were incubated 
for 72 h at 37 °C before analysis. They were then lysed with 1X passive lysis buffer (PLB) 
(50 µL/well) for PLQDQGWKHQWHVWHGIRUȕ-galactosidase expression. Briefly, 50 µL of 
the assay buffer (2 mM magnesium chloride, 100 mM mercaptoethanol, 1.33 mg/mL O-
nitrophenyl- ȕ-D-galactosidase, 200 mM sodium phosphate buffer, pH 7.3) was added to 
each well containing the lysates, before being incubated for 2 h at 37 oC. The absorbance 
of the samples was subsequently read at 405 nm using a Multiskan Ascent plate reader 
(MTX Lab Systems, Bradenton, FL, USA). 
 
Cellular uptake  
To determine whether PEGylation of dendrimers led to lower cellular uptake of the 
complexed DNA, ultimately resulting in lower transfection, B16F10-Luc cells were 
treated with two dendrimer: DNA weight ratios respectively resulting in high and low 
transfection. 
18 
 
Cellular uptake of the fluorescein-labelled DNA complexed to PEGylated 
dendrimers was qualitatively assessed using confocal microscopy. Labelling of plasmid 
DNA with the fluorescent probe fluorescein was performed using a Label IT Fluorescein 
Nucleic Acid Labelling kit, as described by the manufacturer. B16F10-Luc cells were 
seeded at a concentration of 100 000 cells per well on coverslips in 6-well plates and 
grown at 37ºC for 24 h. They were then treated with fluorescein-labelled DNA (2.5 
µg/mL) at different dendrimer: DNA weight ratios of G3-PEG2K (20:1, 2:1), G3-PEG5K 
(20:1, 5:1), G3-PEG10K (20:1, 5:1), G4-PEG2K (10:1, 2:1), G4-PEG5K (20:1, 2:1), G4-
PEG10K (20:1, 5:1), G5-PEG2K (5:1, 2:1), G5-PEG5K (5:1, 2:1) and G5-PEG10K (10:1, 
2:1) for 1 h. G3-, G4- and G5- DAB dendrimers were used as positive controls and naked 
DNA or untreated cells were used as negative controls. 
The cells were then washed three times with 3 mL phosphate buffered saline 
(PBS) before being fixed with 2 mL methanol for 10 min at 25°C. Upon staining of the 
nuclei with Vectashield mounting medium containing DAPI, the cells were examined 
using a Leica TCS SP5 confocal microscope (Wetzlar, Germany). DAPI (staining the cell 
nuclei) was excited with the 405 nm laser line (emission bandwidth: 415-491 nm), while 
fluorescein (which labelled the DNA) was excited with the 514 nm laser line (emission 
bandwidth: 550-620 nm). 
Quantification of cellular uptake was performed using flow cytometry. B16F10-
Luc cells were seeded and treated at various dendrimer: DNA weight ratios of PEGylated 
dendrimers as described for confocal microscopy.   
After 1 h incubation with the treatments, single cell suspensions were prepared (using 
250 µL trypsin per well, followed by 500 µL medium per well once the cells have 
detached), before being analysed using a FACSCanto flow cytometer (BD, Franklin 
Lakes, NJ, USA). Ten thousand cells (gated events) were counted for each sample. Their 
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mean fluorescence intensity was analysed with FACSDiva software (BD, Franklin Lakes, 
NJ, USA). 
 
Statistical Analysis  
Results were expressed as means ± standard error of the mean (S.E.M). Statistical 
significance was determined by analysis of variance (ANOVA) and 2-sample t-tests for 
pair-wise comparisons (Minitab software, State College, PE, USA). Differences were 
considered statistically significant for P values lower than 0.05. 
 
Conclusion 
In this study, we have investigated in vitro a series of PEGylated DAB dendrimers, with 
various PEG molecular weight and dendrimer generations, for potential use as gene 
delivery systems. Our results indicated that G3-DAB dendrimer conjugated to low 
molecular weight PEG (2 kDa) drastically reduced the cytotoxicity of amine-terminated 
DAB dendrimers. G4-DAB conjugated to 2 and 5 kDa PEG also had its cytotoxicity 
reduced, but only at low concentrations (less than 20 µg/ mL). These PEGylated 
dendrimers were still able to condense more than 70 % of the DNA at the dendrimer: 
DNA weight ratios of 5:1 and higher (and even from 2:1 and above for the G4-PEGylated 
DAB dendrimers). At these dendrimer: DNA ratios, the size and zeta potential of the 
resulting dendriplexes were lower than that of unmodified dendriplexes. G3-DAB2K and 
G4-DAB2K dendriplexes at a dendrimer: DNA ratio of 20:1 increased transfection 
compared to the unmodified dendriplex on B16F10-Luc, A431, DU145, PC3-Luc cells 
lines, but not on T98G cell line. G4-DAB5K also increased transfection at a 20:1 ratio, 
but only on A431 cell line. PEGylated G3- and G4-DAB dendrimers may therefore serve 
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as promising scaffolds to build more efficacious and versatile gene delivery systems for 
cancer therapy and should be further evaluated in vivo.  
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Figure captions  
Figure 1. Cytotoxicity of A) generation 3-, B) generation 4- and C) generation 5- DAB 
dendrimers conjugated with PEG of various molecular weights, on B16F10-Luc cancer 
cells (n=15) (black: dendrimer without PEG, dark grey: dendrimer conjugated with PEG 
2 kDa, light grey: dendrimer conjugated with PEG 5 kDa, white: dendrimer conjugated 
with PEG 10 kDa). 
 
Figure 2. DNA condensation of generation 3-DAB (left), generation 4-DAB (middle) 
and generation 5-DAB (right), unmodified or conjugated with PEG2K, PEG5K or 
PEG10K, at various durDWLRQVDQGGHQGULPHU'1$ZHLJKWUDWLRVŶEODFN
Ɣ UHG ŸEOXH źSLQN ƇJUHHQ ŻQDY\DQG'1$Ź
purple). Results are expressed as mean ± SEM (n= 4). 
 
 
Figure 3. Size (left) and zeta potential (right) of the various generations of DAB 
dendriplexes and their PEGylated counterparts (top: generation 3-, middle: generation 4- 
and bottom: generation 5-dendriplexes) at various dendrimer: DNA weight ratios (20:1, 
10:1, 5:1, 2:1, 1:1, 0.5:1). Results are expressed as mean ± SEM (n= 4). 
 
Figure 4. Transfection efficacy of various generations of DAB dendriplexes and their 
PEGylated counterparts at various dendrimer: DNA weight ratios in B16F10-Luc, A431, 
T98G, DU145 and PC3-Luc cancer cell lines. Results are expressed as the mean ± SEM 
of three replicates (n=15). * : P <0.05 vs the transfection levels of unmodified G3-, G4- 
and G5-dendriplexes. Significance is only indicated on the figure if the transfection level 
of PEGylated dendriplex is higher than their unmodified counterpart.  
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Figure 5. Confocal microscopy imaging and flow cytometry quantification of the cellular 
uptake of fluorescein-ODEHOOHG '1$  ȝJZHOO FRPSOH[HG ZLWK *-PEG2K 
(dendrimer: DNA weight ratios: 10:1 and 2:1), G3-PEG5K (dendrimer: DNA weight 
ratios: 20:1 and 2:1), G3-PEG10K (dendrimer: DNA weight ratios: 20:1 and 5:1), G3-
DAB (dendrimer: DNA weight ratio: 2:1) or left uncomplexed, after incubation for 1 h 
with B16F10-Luc cells (Blue: nuclei stained with DAPI (excitation: 405 nm laser line, 
bandwidth: 415-491nm), green: fluorescein-labelled DNA (excitation: 543 nm laser line. 
bandwidth: 550-620 nm) (Bar: 10 µm). 
 
Figure 6. Confocal microscopy imaging and flow cytometry quantification of the cellular 
uptake of fluorescein-ODEHOOHG '1$  ȝJZHOO FRPSOH[HG ZLWK *-PEG2K 
(dendrimer: DNA weight ratios: 10:1 and 2:1), G4-PEG5K (dendrimer: DNA weight 
ratios: 20:1 and 5:1), G4-PEG10K (dendrimer: DNA weight ratios: 20:1 and 3:1), G4-
DAB (dendrimer: DNA weight ratio: 2:1) or left uncomplexed, after incubation for 1 h 
with B16F10-Luc cells (Blue: nuclei stained with DAPI (excitation: 405 nm laser line, 
bandwidth: 415-491nm), green: fluorescein-labelled DNA (excitation: 543 nm laser line. 
bandwidth: 550-620 nm) (Bar: 10 µm). 
 
Figure 7. Confocal microscopy imaging and flow cytometry quantification of the cellular 
uptake of fluorescein-ODEHOOHG '1$  ȝJZHOO FRPSOH[HG ZLWK *-PEG2K 
(dendrimer: DNA weight ratios: 5:1 and 2:1), G5-PEG5K (dendrimer: DNA weight 
ratios: 5:1 and 2:1) , G5-PEG10K (dendrimer: DNA weight ratios: 10:1 and 2:1), G5-
DAB (dendrimer: DNA weight ratio: 2:1) or left uncomplexed, after incubation for 1 h 
with B16F10-Luc cells (Blue: nuclei stained with DAPI (excitation: 405 nm laser line, 
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bandwidth: 415-491nm), green: fluorescein-labelled DNA (excitation: 543 nm laser line. 
bandwidth: 550-620 nm) (Bar: 10 µm). 
 
 
  
29 
 
Table with caption 
Table 1. Cytotoxicity of A) generation 3-, B) generation 4- and C) generation 5- DAB 
dendrimers conjugated with PEG of various molecular weights, expressed as IC50 values, 
on B16F10-Luc cancer cells (n=15) (black: dendrimer without PEG, dark grey: dendrimer 
conjugated with PEG 2 kDa, light grey: dendrimer conjugated with PEG 5 kDa, white: 
dendrimer conjugated with PEG 10 kDa).  
 
 
 
 
 
 
 
 
 
 
 
Dendrimer 
generation
 
IC50 (µg/mL) (mean ± S.E.M.)
 
No PEG
 
PEG-2K
 
PEG-5K
 
PEG-10K
 
G3
 
33.84 ± 2.13
 
> 180
 
>180
 
>180
 
G4
 
16.34 ± 0.51
 
55.49 ± 1.70
 
40.96 ± 1.18
 
>60
 
G5
 
6.04 ± 0.21
 
22.97 ± 0.67
 
21.65 ± 0.41
 
55.05 ± 2.38
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Supplementary Figure 1. A) 1H NMR of G3 DAB, M-PEG2KSCM and G3-PEG2K in 
D20 at 600 MHz, B) Chemical reaction showing conjugation of M-PEG to G3-DAB via 
amide bond. 
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Supplementary Figure 2.  1H NMR (600 MHz) of A) G3-PEG2K, B) G3-PEG5K and 
C) G3-PEG10K in D20.  
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Supplementary Figure 3.  1H NMR (600 MHz) of A) G4-PEG2K, B) G4-PEG5K and 
C) G4-PEG10K in D20. 
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Supplementary Figure 4.  1H NMR (600 MHz) of A) G5-PEG2K, B) G5-PEG5K and 
C) G5-PEG10K in D20.  
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Supplementary Figure 5. Transfection efficacy of various generations of DAB 
dendriplexes at various dendrimer: DNA weight ratios in B16F10-Luc cancer cell line. 
Results are expressed as the mean ± SEM of three replicates (n=15) (Black: generation 
3-DAB, grey: generation 4-DAB, white: generation 5-DAB). * : P <0.05 vs the highest 
transfection level for each dendrimer: DNA weight ratio. 
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Supplementary Table 1. Size of the various generations of DAB dendrimers and their 
PEGylated counterparts. Results are expressed as mean ± SEM (n= 4). 
 
 
 
 
 
 
 
 
 
 
 
 
Dendrimer 
generation
 
Size (nm) (mean ± S.E.M.)
 
No PEG
 
PEG-2K
 
PEG-5K
 
PEG-10K
 
G3
 
1.73 ± 0.02
 
3.14 ± 0.16
 
4.49 ± 0.12
 
6.1 ± 0.13
 
G4
 
2.01 ± 0.04
 
2.23 ± 0.17
 
5.25 ± 0.72
 
6.54 ± 0.27
 
G5
 
2.53 ± 0.07
 
5.45 ± 0.38
 
4.45 ± 0.43
 
6.43 ± 0.24
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Supplementary Table 2. Zeta potential of the various generations of DAB dendrimers 
and their PEGylated counterparts. Results are expressed as mean ± SEM (n= 4). 
 
 
 
 
 
 
 
 
 
 
 
 
Dendrimer 
generation
 
Zeta potential (mV) (mean ± S.E.M.)
 
No PEG
 
PEG-2K
 
PEG-5K
 
PEG-10K
 
G3
 
13.05 ± 0.59
 
9.38 ± 0.77
 
13.08 ± 0.93
 
8.41 ± 0.42
 
G4
 
25.26 ± 0.78
 
16.06 ± 0.29
 
11.80 ± 0.32
 
8.74 ± 0.14
 
G5
 
41.50 ± 1.52
 
36.20 ± 0.20
 
21.38 ± 0.58
 
10.30 ± 0.22
 
 
    
 
 
 
